全文获取类型
收费全文 | 2511篇 |
免费 | 78篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 73篇 |
妇产科学 | 37篇 |
基础医学 | 175篇 |
口腔科学 | 68篇 |
临床医学 | 348篇 |
内科学 | 390篇 |
皮肤病学 | 37篇 |
神经病学 | 98篇 |
特种医学 | 89篇 |
外科学 | 316篇 |
综合类 | 298篇 |
预防医学 | 244篇 |
眼科学 | 29篇 |
药学 | 260篇 |
中国医学 | 28篇 |
肿瘤学 | 109篇 |
出版年
2022年 | 8篇 |
2021年 | 25篇 |
2020年 | 14篇 |
2019年 | 34篇 |
2018年 | 30篇 |
2017年 | 34篇 |
2016年 | 18篇 |
2015年 | 177篇 |
2014年 | 222篇 |
2013年 | 180篇 |
2012年 | 165篇 |
2011年 | 282篇 |
2010年 | 118篇 |
2009年 | 166篇 |
2008年 | 102篇 |
2007年 | 192篇 |
2006年 | 140篇 |
2005年 | 81篇 |
2004年 | 67篇 |
2003年 | 53篇 |
2002年 | 36篇 |
2001年 | 38篇 |
2000年 | 23篇 |
1999年 | 26篇 |
1998年 | 15篇 |
1997年 | 26篇 |
1996年 | 25篇 |
1995年 | 24篇 |
1994年 | 24篇 |
1993年 | 22篇 |
1992年 | 22篇 |
1991年 | 25篇 |
1990年 | 19篇 |
1989年 | 14篇 |
1988年 | 24篇 |
1987年 | 22篇 |
1986年 | 28篇 |
1985年 | 9篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1982年 | 9篇 |
1981年 | 11篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1975年 | 4篇 |
1974年 | 4篇 |
1971年 | 4篇 |
1970年 | 5篇 |
1966年 | 5篇 |
排序方式: 共有2624条查询结果,搜索用时 15 毫秒
81.
【目的】探讨中药浴足治疗闭塞性下肢动脉硬化症的临床疗效。【方法】120例患者随机分为治疗组和对照组,对照组给予丁咯地尔10mg,每日一次静滴,治疗组在此基础上加用自拟中药方煎煮浴足,每日一次,于治疗前后,第1、2周末对足疼痛发作频次、持续时间、疼痛程度和踝肱指数(ABI)进行测评。【结果】加用中药浴足组在减少足静息痛发作频次、缩短每次发作持续时间、减轻疼痛程度、改善ABI及降低复发方面,均明显优于单用丁咯地尔组。【结论】中药浴足加丁咯地尔治疗闭塞性下肢动脉硬化症有较好疗效。 相似文献
82.
目的评估表观扩散系数(ADC)及MR动态增强(DCE-MRI)对前列腺中央腺体病变的诊断价值。方法对经病理证实的50例前列腺中央腺体疾病患者进行扩散加权扫描(DWI)和DCE-MRI扫描,其中16例为前列腺癌(PCa),34例为前列腺增生(BPH)。分析基质增生为主型BPH(sBPH)、腺体增生为主型BPH(gBPH)和PCa的ADC值差别特点及信号强度-时间(SI-T)曲线特征。结果 gBPH、sBPH和PCa的平均ADC值分别为(1.33±0.25)×10-3 mm2/s、(1.04±0.22)×10-3 mm2/s、(0.71±0.32)×10-3 mm2/s,两两比较各组间有统计学差异(P<0.05)。SI-T曲线参数:达峰时间(Tmax)从高到低依次为sBPH、gBPH及PCa(P<0.05),强化程度(SI%)从高到低依次为sBPH、PCa及gBPH(P<0.05),强化率(R)从高到低依次为PCa、gBPH及sBPH(P<0.05)。结论 MR动态增强及ADC对前列腺中央腺体的病变有重要的诊断价值。 相似文献
83.
背景:中央脊髓综合征是常见的不完全性颈脊髓损伤,目前关于其手术与非手术处理的利与弊仍是脊柱外科争论的焦点。目的:探讨中央脊髓综合征的手术治疗效果及预后。方法:回顾性分析2009年1月至2012年6月采用手术治疗的34例中央脊髓综合征患者的临床资料,男24例,女10例;年龄39~76岁,平均53.6岁;前路手术26例,后路手术8例。采用日本骨科协会(JOA)评分标准对患者神经功能进行评定,记录所有患者术前、术后6个月及末次随访的JOA评分,评估手术疗效并分析其预后情况。结果:34例患者全部获得随访,随访时间为6~23个月,平均(14.5±3.8)个月。术前JOA评分平均为(8.8±1.8)分,术后6个月提高至(13.9±2.1)分,末次随访为(14.6±1.5)分。术后6个月及末次随访时的评分改善率分别为(66.1±21.6)%和(73.6±15.2)%。术后1例发生脑脊液漏,1例发生硬膜外血肿,无一例发生椎动脉损伤、切口感染、内固定物失败等并发症。结论:手术解除椎管内的压迫是治疗中央脊髓综合征的有效方法。对于诊断明确的中央脊髓综合征,在全身情况允许的条件下,宜早期根据椎管内脊髓损伤的节段、压迫来源及程度等选择相应的手术方案,以改善脊髓内血供,减少脊髓继发性损害,促进神经功能的改善和恢复。 相似文献
84.
大鼠原位肝脏低温灌注和复流模型的建立及意义 总被引:8,自引:0,他引:8
目的建立一种大鼠肝脏原位低温灌注再复流模型,用于离体及活体供肝肝切除术的研究。方法大鼠78只,分成4组,A、B组分别用乳酸林格氏液和自制灌注液灌注,C组仅行全肝血流阻断,D组作正常对照。脾静脉和右肾上腺静脉分别作为灌注液流入和流出道,行在体原位低温灌注,观察再复流后对肝细胞和肝窦内皮细胞的影响。结果C组再复流2h和6h血清透明质酸浓度为(250.0±24.1)μg/L、(290.4±37.0)μg/L,分别高于A组(142.9±30.1)μg/L、(200.0±17.5)μg/L,差异均有非常显著性(P<0.01);B组浓度为(63.3±16.2)μg/L、(62.1±14.6)μg/L,与A组相比浓度更低(P<0.01)。结论该模型方法简单,易成功,可用于离体和活体供肝肝切除防止肝脏损伤的研究。 相似文献
85.
目的探讨人参总皂甙对肾结石体外冲击波碎石(ESWL)后血管活性物质的调控作用。方法选择单侧肾盂或肾盏结石患者40例,随机分为用药组和对照组,采用水囊式JT-Ⅱ型碎石机,工作电压为10.5~12.0kV,冲击2300~2500次,用药组碎石前15min滴注人参总皂甙20g,对照组仅滴生理盐水,碎石前后测定血栓素(TXA2)、前列环素(PGI2)和内皮素-1(ET-1)。结果
ESWL后6h,TXB2在用药组(1317.6±118.7)ng/L和对照组(2476.5±132.6)ng/L达最高峰,两组比较差异有非常显著性(P<0.01);PGF1α在用药组术后24h(2243.6±212.4)ng/L达高峰,对照组术后24h(1168.6±157.4)ng/L,两组比较差异有非常显著性(P<0.01),ET-1在术后6h达高峰,用药组(668.9±72.5)ng/L和对照组(1016.8±137.5)ng/L比较差异有非常显著性(P<0.01)。结论人参总皂甙通过调控ESWL后血管活性物质的水平达到扩张血管、疏通微循环及保护肾功能的作用。 相似文献
86.
87.
Cholangiocarcinoma: the "other" liver cancer on the rise 总被引:1,自引:0,他引:1
88.
<正>舍格伦综合征在临床上较为多见,主要症状为眼干、口干、唾液腺及泪腺肿大,病程较长。而以多涎腺急性肿胀为表现的舍格伦综合征尚未见文献报道,笔者在临床上遇见1例,现报道如下。1病例资料患者女性,64岁,2008-09-17入院,病案号:087522。患者于2008-09-13吃晚饭时发现双侧下颌下肿胀,核桃般大小,晚上睡觉时发现肿胀变大并向上发展。第2天肿胀进一步加重并出现明显口干症状,于村卫生所静脉滴注青霉素、双黄连3 d,病情无好转并又出现声嘶症状,前来我院就诊。门诊以"①双侧腮腺、颌下腺及舌下腺肿大待查;②颌 相似文献
89.
Benjamin R. Hanisch Blachy J. Davila Saldana Michael D. Keller Xiaoyan Song 《Journal of clinical immunology》2018,38(7):804-809
Purpose
Patients with primary immunodeficiency diseases (PID) are perceived to be at high risk for acquiring as well as developing complications from infections. There is little data describing the infection type and frequency these patients may acquire in the community or during hospital admissions. Data is critically needed in order to inform best practices on how to protect these vulnerable patients.Methods
This is a retrospective study which included PID patients who were discharged from Children’s National Health System (CNHS) from January 1, 2011, through August 31, 2017, and were assigned a discharge diagnosis code indicating PID. Hospitalizations that occurred in the study period were reviewed to extract information on the type of infections upon admission and during hospitalization. The rate of hospital acquired infections (HAIs) was calculated by the number of HAIs divided by the total number of days between date of admission and date of discharge or receiving the first bone marrow transplant, whichever the one came first. The rates were then compared to the HAI rate among oncology patients receiving treatment at CNHS during the same study period.Results
During this study period, 33 PID patients were admitted 80 times for a total of 1855 patient days. Of these 80 admissions, 31 were due to an infection. Ten of the 31 admissions with severe combined immunodeficiency disease (SCID) were infection related, 4/4 in ectodermal dysplasia with immunodeficiency due to gain of function mutation (IkappaBalpha) patients, 8/10 in Wiskott-Aldrich patients, 1/2 in STAT3 mutation patients, 1/1 in Hyper IGM patient, 1/5 in severe chronic active EBV (SCAEBV) patients, 1/1 NK defect, 2/21 in primary hemophagocytic lymphohistiocytosis patients, 3/4 chronic granulomatous disease, and 0/1 congenital neutropenia. HAI occurred in 11 out of 80 admissions (13.75%). Patients with SCID had the highest HAI rate of 13.09 per 1000 patient days, followed by SCAEBV (11.10), IkappaBalpha (6.58), and Wiskott-Aldrich (4.91). Comparing to oncology patients in which the HAI rate was 0.92 per 1000 patient days. SCID patients had 11.7 (95% confidence interval 3.7–29; p?<?0.001) and T cell defects excluding SCID had 4.8 (95% CI 1.0–14.8; p?=?0.03) times greater risk of acquiring an infection during a hospitalization.Conclusions
Patients with severe T cell defects such as SCID are at greater risk for infections in the community and in hospital settings. Additional infection prevention measures are likely needed when caring for these patients in a clinic or as an inpatient. Further studies are urgently needed to determine the most appropriate measures for these patients.90.
John C. Anthes Robert W. Bryant Mark W. Musch Kwokei NG Marvin I. Siegel 《Inflammation》1986,10(2):145-156
The human promyelocytic leukemia cell line HL60 can be differentiated to mature granulocytes upon exposure to DMSO (1.3%, 6 days). The ability of these cells to metabolize arachidonic acid via the 5-lipoxygenase pathway to form 5-HETE, LTB4, and 5,12-diHETEs, has been previously documented. However, the production of peptidoleukotrienes by DMSO-differentiated HL60 cells has not been previously reported. Arachidonic acid metabolites produced via 5-lipoxygenase were identified by reverse-phase, high-performance liquid chromatography, immunoreactivity specific for peptidoleukotriene, glutamyl transpeptidase transformation, characteristic UV spectra, and GC mass spectra. Leukotriene synthesis in the DMSO-differentiated HL60 cell is maximal at 5 min when stimulated with the calcium ioniphore, A23187 (1M), in the presence of calcium. These cells produce 12.94±1.8 ng/106 cells of LTC4 and 3.8±0.4 ng/106 cells of LTB4. LTC4 and LTB4 are also synthesized in the undifferentiated cell when stimulated with 1M A23187 and 1 mM Ca2+, but in much smaller quantities, i.e., 1.91±0.42 ng/106 cells of LTC4 and 0.41 ng±0.06/106 cells of LTB4. The synthetic chemotactic peptide, f-Met-Leu-Phe, also elicits formation of LTC4 and LTB4 in a dose-dependent manner in the presence of exogenously added calcium. Maximal stimulation of DMSO-differentiated cells with f-Met-Leu-Phe produces 2.5±0.2 ng of LTC4 and 1.45±0.2 ng of LTB4 per 106 cells. The observation that DMSO-differentiated HL60 cells produce LTC4, as well as other 5-lipoxygenase products, increases the utility of this cell line for unraveling the regulation of leukotriene biosynthesis by granulocytes. 相似文献